VRNA - Verona Pharma PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRNA is currently covered by 7 analysts with an average price target of $28.96. This is a potential upside of $14.17 (95.81%) from yesterday's end of day stock price of $14.79.

Verona Pharma PLC ADR's activity chart (see below) currently has 17 price targets and 44 ratings on display. The stock rating distribution of VRNA is 96.55% BUY and 3.45% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.38% with an average time for these price targets to be met of 509.5 days.

Highest price target for VRNA is $38, Lowest price target is $32, average price target is $28.96.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 04-Mar-2024. First documented stock forecast 22-May-2017.

Currently out of the existing stock ratings of VRNA, 28 are a BUY (96.55%), 1 are a SELL (3.45%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

32

$17.21 (116.36%)

32

2 months 4 days ago

2/14 (14.29%)

$14.72 (85.19%)

471

Buy

33

$18.21 (123.12%)

30

2 months 7 days ago

3/6 (50%)

$14.81 (81.42%)

790

Buy

35

$20.21 (136.65%)

35

8 months 7 days ago

4/9 (44.44%)

$15.6 (80.41%)

631

Buy

32

$15.27 (91.27%)

32

10 months 11 days ago

2/6 (33.33%)

$11.78 (58.26%)

206

Buy

38

$23.21 (156.93%)

17

11 months 16 days ago

1/2 (50%)

$16.67 (78.15%)

847

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRNA (Verona Pharma PLC ADR) average time for price targets to be met?

On average it took 509.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.38

Which analyst has the current highest performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?

SUJI JEONG

Which analyst has the most public recommendations on VRNA (Verona Pharma PLC ADR)?

Raghuram Selvaraju has 3 price targets and 16 ratings on VRNA

Which analyst is the currently most bullish on VRNA (Verona Pharma PLC ADR)?

Yatin Suneja with highest potential upside - $24.14

Which analyst is the currently most reserved on VRNA (Verona Pharma PLC ADR)?

Andreas Argyrides with lowest potential downside - $15.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?